Literature DB >> 12504566

Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection.

Bin Wang1, Wayne B Dyer, John J Zaunders, Meriet Mikhail, John S Sullivan, Lisa Williams, Da'ed N Haddad, Graeme Harris, John A G Holt, David A Cooper, Monica Miranda-Saksena, Ross Boadle, Anthony D Kelleher, Nitin K Saksena.   

Abstract

We recently demonstrated that a unique HIV-1-infected nonprogressor was infected with a nonevolving replication-incompetent HIV-1 strain, showing a total absence of viral evolution in vivo. Potent immune responses against HIV-1 were observed in his PBMC, despite an apparent lack of viral replication for at least 8 years. His PBMC resisted superinfection with CCR5, CXCR4, and dual-tropic HIV-1 strains, although highly purified CD4+ T cells supported infection, but without any visible cytopathic effect. Potent noncytolytic CD8+ T cell antiviral activity was shown to protect his PBMC from productive infection. This activity was not mediated by several known chemokines or IFN-gamma, which were produced at high levels after PHA activation of his CD8+ T cells, indicating the action of other CAF-like CD8 factors. This antiviral activity was a memory response, induced by HIV-specific stimulation to similar levels observed by PHA stimulation, but absent in ex vivo resting T cells. Immunological mechanisms associated with this antiviral suppressive activity included vigorous Gag-specific helper T cell proliferative responses and high-level IFN-gamma release by both CD4 and CD8 T cells. These responses were broadly directed against multiple Gag epitopes, both previously reported and some novel epitopes. Strong HIV-specific helper T cell function was also associated with strong neutralizing antibodies. Understanding how to induce these protective immune responses in other individuals could provide a major step forward in the design of effective immunotherapies or vaccines against HIV infection. Copyright 2002 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12504566     DOI: 10.1006/viro.2002.1706

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.

Authors:  Helene Mens; Mary Kearney; Ann Wiegand; Wei Shao; Kristian Schønning; Jan Gerstoft; Niels Obel; Frank Maldarelli; John W Mellors; Thomas Benfield; John M Coffin
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Authors:  Daniel Mendoza; Sarah A Johnson; Bennett A Peterson; Ven Natarajan; Maria Salgado; Robin L Dewar; Peter D Burbelo; Nicole A Doria-Rose; Erin H Graf; Jamieson H Greenwald; Jessica N Hodge; William L Thompson; Nancy A Cogliano; Cheryl L Chairez; Catherine A Rehm; Sara Jones; Claire W Hallahan; Joseph A Kovacs; Irini Sereti; Omar Sued; Sheila A Peel; Robert J O'Connell; Una O'Doherty; Tae-Wook Chun; Mark Connors; Stephen A Migueles
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

3.  Characterization of circulating HIV type 1 env genes in plasma of two antiretroviral-naive slow progressing patients with broad neutralizing antibody response with evidence of recombination.

Authors:  Sampurna Mukhopadhyay; Rajesh Ringe; Ajit Patil; Ramesh Paranjape; Jayanta Bhattacharya
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-07       Impact factor: 2.205

4.  CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors.

Authors:  Karen A O'Connell; S Alireza Rabi; Robert F Siliciano; Joel N Blankson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

5.  Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection.

Authors:  S Alireza Rabi; Karen A O'Connell; Daria Nikolaeva; Justin R Bailey; Benjamin L Jilek; Lin Shen; Kathleen R Page; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

Review 6.  Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

Authors:  Joel N Blankson
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

7.  The interplay between the X-DING-CD4, IFN-α and IL-8 gene activity in quiescent and mitogen- or HIV-1-exposed PBMCs from HIV-1 elite controllers, AIDS progressors and HIV-negative controls.

Authors:  Rakhee Sachdeva; Rasheda Y Shilpi; Malgorzata Simm
Journal:  Innate Immun       Date:  2013-06-10       Impact factor: 2.680

8.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.

Authors:  Asier Sáez-Cirión; Christine Lacabaratz; Olivier Lambotte; Pierre Versmisse; Alejandra Urrutia; Faroudy Boufassa; Françoise Barré-Sinoussi; Jean-François Delfraissy; Martine Sinet; Gianfranco Pancino; Alain Venet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

9.  Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.

Authors:  Nancy C Connolly; Theresa L Whiteside; Cara Wilson; Venkatswarlu Kondragunta; Charles R Rinaldo; Sharon A Riddler
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

10.  Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.

Authors:  John Zaunders; David van Bockel
Journal:  Front Immunol       Date:  2013-04-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.